Print Page

給 醫 護 專 業 人 員 的 信
 
Moderna and Pfizer-BioNTech COVID-19 vaccines: increased risks of myocarditis and pericarditis (Letter to Healthcare Professionals) (English only)
 
 
 
附件:
  1. Moderna and Pfizer-BioNTech COVID-19 vaccines: increased risks of myocarditis and pericarditis (English only)  
Related Information:
FDA approves required updated warning in labeling of mRNA COVID-19 Vaccines rega... 上載於 2025-06-26
The United States: FDA approves required updated warning in labeling of mRNA COV... 上載於 2025-06-26
European Union: PRAC update on risk of myocarditis and pericarditis with mRNA va... 上載於 2021-12-04
European Union: PRAC assessing further data on risk of myocarditis and pericardi... 上載於 2021-10-30
Australia: Pfizer COVID-19 vaccine (Comirnaty) - Addition of safety information ... 上載於 2021-07-24
European Union: Comirnaty and Spikevax: possible link to very rare cases of myoc... 上載於 2021-07-10
The United Kingdom: COVID-19 vaccines: Review of extremely rare reports of myoca... 上載於 2021-07-08
Canada: Health Canada updates Pfizer-BioNTech and Moderna COVID-19 vaccine label... 上載於 2021-07-02
The United States: Moderna and Pfizer-BioNTech COVID-19 vaccines: increased risk... 上載於 2021-06-26
European Union: COVID-19 vaccines: update on ongoing evaluation of myocarditis a... 上載於 2021-06-12
 
back